Production & Manufacturing
Janssen Submits Application to U.S. FDA to Expand Indication for Daratumumab
Janssen Biotech, Inc. announced a supplemental Biologics License Application (sBLA) for daratumumab (DARZALEX®) has been submitted to the U.S. FDA . ...
Press Releases
FDA Approves Troxyca ER Capsules with Abuse-Deterrent Properties for the Management of Pain
Pfizer Inc announced that the U.S. Food and Drug Administration (FDA) has approved Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride) extended-release capsules, for oral...
Drug Research
Researchers develop safer opioid painkiller from scratch
An international team of researchers - led by scientists at UC San Francisco, Stanford University, the University of North Carolina (UNC), and the Friedrich-Alexander...
Drug Research
ViiV Healthcare Begins Phase III Programme To Evaluate Two-drug Regimen For HIV-1 Treatment
ViiV Healthcare announced the start of a phase III programme to support regulatory filings for a two-drug regimen of dolutegravir (Tivicay®) and lamivudine (Epivir®)...
Clinical Trials
KalVista begins phase 1 study of KVD818 in hereditary angioedema
KalVista Pharmaceuticals announced the dosing of the first subject in a first-in-human clinical trial to evaluate the safety, pharmacokinetics and pharmacodynamics of orally delivered...
Clinical Trials
Alzheimer’s drug shows promise for patients in phase III trial
At the Alzheimer's Association International Conference 2016 (AAIC 2016), held in Toronto, Canada, researchers reveal how a drug called LMTX shows promise for halting...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read